← Back to Search

Brain Health Assessment for Dementia

N/A

Waitlist Available

Led By Deborah Barnes, PhD

Research Sponsored by Kaiser Permanente

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No prior diagnosis of dementia (defined from EHR diagnosis codes) and not receiving medications for dementia

Be older than 65 years old

Must not have

Currently receiving hospice care

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months after invitation mailed

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new, cheaper way to detect dementia in primary care settings.

Who is the study for?

This trial is for individuals who are active patients at participating clinics, have not been diagnosed with dementia or Alzheimer's Disease, and aren't on medications for these conditions. They must also have enough data available to calculate what's called an eRADAR score. People currently in hospice care cannot participate.

What is being tested?

The study is testing a new strategy to detect dementia early in primary care settings by using a Brain Health Assessment tool. It aims to be low-cost and patient-friendly while improving the identification of cognitive issues.

What are the potential side effects?

Since this trial involves an assessment rather than medication or invasive procedures, there are no direct physical side effects associated with the intervention being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have never been diagnosed with dementia nor am I on dementia medication.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently in hospice care.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months after invitation mailed

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months after invitation mailed

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after invitation mailed for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

New dementia diagnoses

Secondary study objectives

Clinic "no shows"

Dementia medications

Healthcare utilization

+7 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Brain Health InterventionExperimental Treatment1 Intervention

* Calculate eRADAR scores using EHR data to identify eligible individuals * Invite eligible individuals for brain health assessment visit * Enter results of brain health assessment visit into EHR * Provide summary of results and recommended next steps to the Primary Care Physician and participant

Group II: Usual careActive Control1 Intervention

Individuals who meet eligibility criteria will receive usual care.

0 / 2Eligibility criteria met